Kymera Therapeutics Inc. (KYMR)
Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary 
XKLS $
115. 77
+1.78
+1.5615%
$
9.22B Market Cap
- P/E Ratio
- Div Yield
720,700 Volume
-2.54 Eps
$ 113.99
Previous Close 
Want to track KYMR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
KYMR Earnings Reports FAQ
What is the earnings per share (EPS) for KYMR?
The current EPS is -2.54.
What is the company's earnings growth rate?
Kymera Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Kymera Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Kymera Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for KYMR at this time, as Kymera Therapeutics Inc has no recent EPS data to calculate it.
